121 related articles for article (PubMed ID: 15864214)
1. From pancreatic intraepithelial neoplasia to cancer: a dramatic progression with K-ras status analysis.
Fernandez C; Chetaille B; Tasei AM; Sastre B; Sahel J; Payan-Defais MJ
Gastroenterol Clin Biol; 2005 Apr; 29(4):465-8. PubMed ID: 15864214
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
[TBL] [Abstract][Full Text] [Related]
3. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
Rosty C; Geradts J; Sato N; Wilentz RE; Roberts H; Sohn T; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Am J Surg Pathol; 2003 Dec; 27(12):1495-501. PubMed ID: 14657708
[TBL] [Abstract][Full Text] [Related]
4. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
5. Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).
Koorstra JB; Feldmann G; Habbe N; Maitra A
Langenbecks Arch Surg; 2008 Jul; 393(4):561-70. PubMed ID: 18283486
[TBL] [Abstract][Full Text] [Related]
6. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.
Goggins M; Hruban RH; Kern SE
Am J Pathol; 2000 May; 156(5):1767-71. PubMed ID: 10793087
[TBL] [Abstract][Full Text] [Related]
7. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
8. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
9. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
10. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
[TBL] [Abstract][Full Text] [Related]
11. Lack of apoptosis in PanIN-1 and PanIN-2 lesions associated with pancreatic ductal adenocarcinoma is not dependent on K-ras status.
Lüttges J; Neumann S; Jesenofsky R; Borries V; Löhr M; Klöppel G
Pancreas; 2003 Oct; 27(3):e57-62. PubMed ID: 14508142
[TBL] [Abstract][Full Text] [Related]
12. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
13. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
14. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.
Guerra C; Schuhmacher AJ; Cañamero M; Grippo PJ; Verdaguer L; Pérez-Gallego L; Dubus P; Sandgren EP; Barbacid M
Cancer Cell; 2007 Mar; 11(3):291-302. PubMed ID: 17349585
[TBL] [Abstract][Full Text] [Related]
15. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
16. [Pancreatic intraepithelial neoplasia in chronic pancreatitis].
Tannapfel A; Witzigmann H; Wittekind C
Zentralbl Chir; 2001 Nov; 126(11):879-83. PubMed ID: 11753797
[TBL] [Abstract][Full Text] [Related]
17. Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
Dergham ST; Dugan MC; Arlauskas P; Du W; Vaitkevicius VK; Crissman JD; Sarkar FH
Int J Pancreatol; 1997 Jun; 21(3):225-34. PubMed ID: 9322121
[TBL] [Abstract][Full Text] [Related]
18. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for familial pancreatic cancer.
de Vos tot Nederveen Cappel WH; Lagendijk MA; Lamers CB; Morreau H; Vasen HF
Scand J Gastroenterol Suppl; 2003; (239):94-9. PubMed ID: 14743890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
